Characterization and Secondary Structure Analysis of Endostatin Covalently Modified by Polyethylene Glycol and Low Molecular Weight Heparin
スポンサーリンク
概要
- 論文の詳細を見る
- Japanese Biochemical Societyの論文
- 2008-08-01
著者
-
Yang Shenglin
Institute Of Biochemical And Biotechnological Drug School Of Pharmaceutical Science Shandong Univers
-
Wang Fengshan
Institute Of Biochemical And Biotechnological Drug School Of Pharmaceutical Science Shandong Univers
-
Liu Chunhui
Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Shandong Uni
-
Liu Chunhui
Institute Of Biochemical And Biotechnological Drug School Of Pharmaceutical Science Shandong Univers
-
TAN Haining
Institute of Biochemical and Biotechnological Drug, School of Pharmaceutical Science, Shandong Unive
-
FENG You
Institute of Biochemical and Biotechnological Drug, School of Pharmaceutical Science, Shandong Unive
-
CAO Jichao
Institute of Biochemical and Biotechnological Drug, School of Pharmaceutical Science, Shandong Unive
-
MU Guoying
Jinan Central Hospital and Clinical Medical College of Shandong University
-
Feng You
Institute Of Biochemical And Biotechnological Drug School Of Pharmaceutical Science Shandong Univers
-
Cao Jichao
Institute Of Biochemical And Biotechnological Drug School Of Pharmaceutical Science Shandong Univers
-
Tan Haining
Institute Of Biochemical And Biotechnological Drug School Of Pharmaceutical Science Shandong Univers
-
Mu Guoying
Jinan Central Hospital Affiliated to Shandong University and Clinical Medical College of Shandong University
関連論文
- Isolation and Structural Characterization of a Novel Polysaccharide Prepared from Arca subcrenata Lischke(BIOCHEMICAL ENGINEERING)
- Characterization and Secondary Structure Analysis of Endostatin Covalently Modified by Polyethylene Glycol and Low Molecular Weight Heparin
- Down-Regulation of Vascular Endothelial Growth Factor and Up-Regulation of Pigment Epithelium Derived Factor Make Low Molecular Weight Heparin-Endostatin and Polyethylene Glycol-Endostatin Potential Candidates for Anti-angiogenesis Drug